June 22, 2026
Pharma Market Access Challenges Shape European Competitiveness
Nathalie Moll, Director General of EFPIA, sets out why pharma market access now…
June 15, 2026
Portugal Access Delays Influence Reimbursement Strategies
Portugal access delays remain a defining challenge for health systems seeking to balance…
June 8, 2026
Incretin Economics: Strategic Lessons from New Obesity Therapies
The accelerating development of incretin-based therapies demands fresh thinking on incretin economics. Recent…
June 1, 2026
US Drug Pricing Trends and Global Comparisons
US drug pricing continues to shape debates on affordability and market access. Recent…
May 25, 2026
Barriers to Gene Therapy Access in Europe
Gene therapy access continues to challenge healthcare systems across Europe despite clear patient…
May 18, 2026
Why Indirect Healthcare Costs Deserve Greater Attention
Many reimbursement decisions still overlook indirect healthcare costs. These expenses arise from lost…